Pacer Swan SOS Flex (July) ETF (PSFJ)
Live price chart, market sentiment, and community perspectives for Pacer Swan SOS Flex (July) ETF (CBOE: PSFJ).
Live price chart, market sentiment, and community perspectives for Pacer Swan SOS Flex (July) ETF (CBOE: PSFJ).
On our desk, we've been tracking the unusual jump in short interest for PSFJ, which shot up 638.9% in July to 60,018 shares. With about 7.7% of the fund's shares sold short and a short-interest ratio hovering near 5.2 days based on average daily trading volumes of 11,582 shares, this creates an interesting tactical dynamic that options desks and hedge funds are starting to weigh more closely against institutional positions like Advisory Services Network's new stake.
From a risk management standpoint, the structural design of PSFJ is fascinating. Over an approximate one-year period pegged to the SPDR SandP 500 ETF Trust, it buffers investors against the initial -20% downside. However, between -20% and -40%, the fund declines 2% for every 1% drop in the underlying, before aligning back to a 1-to-1 decline past -40%. On the upside, participation is capped at 16.40% before fees and expenses.
Looking at quantitative metrics from Danelfin's AI-powered analysis, PSFJ currently maintains a score of 5 out of 10, translating to a 'Hold' rating with a 61% probability of outperforming the broader ETF universe over the next 3 months. Technical factors like the Deca-Chart Pattern and RSI 180 are providing positive contributions, though near-term strong sentiment sits alongside a neutral mid-to-long term outlook.
As a market analyst evaluating institutional trading flows, I note that newer participants like Calton and Associates Inc. and Advisory Services Network LLC have initiated positions during the third quarter. This institutional interest contrasts sharply with the recent short interest surge, suggesting a tug-of-war between tactical short-term hedging and long-term structured outcome accumulation.
From our quantitative desk, liquidity mapping around PSFJ price events indicates that neutral sentiment is prevailing overall, but there are no clear price positioning signals or overhead resistance levels above the current price of 35.86, pointing to compelling upside potential if market momentum holds steady through the roll period.
Explore plasma cleansing, somatic organ swaps, and BCI.